Covered recipient · General Payments record
CAITLIN M ASHLEY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,142.87
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.43 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $296.34 | 28 |
| Alkermes, Inc. | $114.83 | 5 |
| Otsuka America Pharmaceutical, Inc. | $45.46 | 2 |
| Exact Sciences Corporation | $20.77 | 1 |
| Acerta Pharma LLC | $16.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.03 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457218 | CMS |
| ABBVIE INC. | $2.50 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457220 | CMS |
| ABBVIE INC. | $8.89 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457222 | CMS |
| ABBVIE INC. | $16.52 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457224 | CMS |
| ABBVIE INC. | $30.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457226 | CMS |
| ABBVIE INC. | $10.84 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457228 | CMS |
| ABBVIE INC. | $13.11 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457230 | CMS |
| ABBVIE INC. | $13.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457232 | CMS |
| ABBVIE INC. | $3.49 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457234 | CMS |
| ABBVIE INC. | $18.20 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457236 | CMS |
| ABBVIE INC. | $5.94 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457238 | CMS |
| ABBVIE INC. | $8.04 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457240 | CMS |
| ABBVIE INC. | $18.72 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457242 | CMS |
| ABBVIE INC. | $4.06 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457244 | CMS |
| ABBVIE INC. | $16.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457246 | CMS |
| ABBVIE INC. | $2.30 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457248 | CMS |
| ABBVIE INC. | $10.12 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457250 | CMS |
| ABBVIE INC. | $7.34 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457252 | CMS |
| ABBVIE INC. | $11.52 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457254 | CMS |
| ABBVIE INC. | $3.25 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457256 | CMS |
| ABBVIE INC. | $10.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457258 | CMS |
| ABBVIE INC. | $20.20 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457260 | CMS |
| ABBVIE INC. | $6.64 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457262 | CMS |
| ABBVIE INC. | $4.73 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457264 | CMS |
| ABBVIE INC. | $6.95 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457266 | CMS |
| ABBVIE INC. | $4.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457268 | CMS |
| ABBVIE INC. | $4.47 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457270 | CMS |
| ABBVIE INC. | $4.32 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457272 | CMS |
| Alkermes, Inc. | $22.34 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460071 | CMS |
| Alkermes, Inc. | $28.31 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460073 | CMS |
| Alkermes, Inc. | $19.71 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460075 | CMS |
| Alkermes, Inc. | $15.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460077 | CMS |
| Alkermes, Inc. | $29.05 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460079 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.03 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104581900 | CMS |
| Exact Sciences Corporation | $20.77 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114513814 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.90 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119018386 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.56 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119018388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.